Modular Ultrasonic Beacon System (MUBS) for Ultrasound-guided Interventional Surg
Modular Ultrasonic Beacon System (MUBS) for Ultrasound-guided Interventional Surg
批准号:
8589815
负责人:
Thomas Cummins
金额:
$20.1万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2013
资助国家:
美国
项目状态:
已结题
起止时间:
2013-09-15 至 2015-01-31
关键词:
AdoptionAlgorithmsBackBiopsyBreastCaringCost SavingsCustomDataDetectionDevicesDistalDropsElectronicsEquilibriumFailureFosteringFutureGenerationsGoalsHealthcare SystemsHousingImageImage EnhancementImageryInterventionLearningLegal patentLocationManufacturer NameMedicalMedical DeviceMethodsModalityMonitorNeedle biopsy procedureNeedlesNerve BlockOperative Surgical ProceduresPhasePhysiologic pulsePlayPower SourcesPrintingProblem SolvingProceduresProviderResearchResearch PersonnelRiskSafetySamplingSchemeSignal TransductionSolutionsSystemTissuesTrainingTransducersUltrasonic TherapyUltrasonic TransducerUltrasonicsUltrasonographyUnnecessary SurgeryWomananalogbasebreast cancer diagnosiscommercializationcomputerized data processingcostcost effectivenessdesignhazardimaging probeinnovationinnovative technologiesmanufacturing processminiaturizeminimally invasivenovelpatient safetyprototypepublic health relevancesoft tissuestandard of caretool
中文摘要
描述(由申请人提供):每年有160万美国女性接受乳腺癌活检诊断。幸运的是,越来越少的女性接受开放性手术活检,而是接受微创图像引导下的穿刺活检。超声成像引导是这种干预的主要方式,因为它提供了安全性,患者舒适度,方便性和成本效益的最大平衡。然而,尽管超声成像安全方便,但其成像质量仍然高度依赖于操作人员。由于超声波是软组织成像的最佳选择,而不是金属工具(如针头),这个问题更加严重。这对许多潜在的从业者来说是一个新的障碍:超声引导针基干预是困难的,需要大量的培训。ClariTrac Inc.是一家旨在解决这一问题的初创医疗设备公司。具体来说,ClariTrac正在开发一种正在申请专利的模块化超声信标系统(MUBS),该系统主要由一个一次性的微型硬件组件组成,可与针头的尖端或轴或其他介入工具相结合。MUBS是一个完全集成的超声换能器与电子和互连。MUBS的工作原理就像一个信标:它等待待机,以探测从超声成像探头发出的超声能量。在探测到探测器的能量后,MUBS又以马可波罗的方式主动地将能量传回探测器。这种返回的能量在超声图像上显示为一个明亮的、可定制的标记,代表介入工具的精确位置。我们假设这个标记将允许护理提供者更容易和精确地执行程序。我们的最终目标是设计硬件,作为未来超声介入工具创新的低成本平台。这些应用扩展到神经阻滞和线路放置,从图像增强到成像、组织表征、监测和治疗。
英文摘要
DESCRIPTION (provided by applicant): Each year 1.6 million US women undergo biopsy for breast cancer diagnosis. Fortunately fewer and fewer women suffer through open surgical biopsy but rather receive minimally invasive image-guided needle based biopsy. Ultrasound imaging guidance is the dominant modality for this intervention as it offers the greatest balance of safety, patient comfort, expediency, and cost effectiveness. However, for all its safety and convenience, ultrasound imaging quality remains strongly operator dependent. This problem is exacerbated by the fact that ultrasound is optimal for imaging soft tissue and not metallic tools such as needles. What this presents is a new barrier for adoption amongst many would-be practitioners: ultrasound guided needle-based interventions are difficult and require substantial training. ClariTrac Inc. is a startup medical device company that aims to solve this problem. Specifically, ClariTrac is developing a patent pending Modular Ultrasonic Beacon System (MUBS) that consists mainly of a disposable, miniature hardware component to be incorporated with the tip or shaft of needles or other interventional tools. The MUBS is a fully integrated ultrasound transducer with electronics and interconnection. The operating principle of the MUBS is like a beacon: it waits in stand-by to detect ultrasound energy emitted from the ultrasound imaging probe. Upon detecting the probe's energy, the MUBS in turn actively transmits energy back to the probe, in a marco-polo fashion. This returned energy appears as a bright, customizable marker on the ultrasound image that represents the precise location of the interventional tool. We hypothesize this marker will allow the care- provider to perform the procedure with greater ease and precision. Our ultimate goal is to design hardware that serves as a low-cost platform for future innovation in ultrasound enabled interventional tools. These applications extend to nerve block and line-placement, beyond image enhancement to imaging, tissue characterization, monitoring and therapy.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
海外基金